Abstract
WHIM syndrome is an immunodeficiency disease characterized by neutropenia, hypogammaglobulinemia and extensive human papillomavirus (HPV) infection1. Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain abundant mature myeloid cells, a condition termed myelokathexis2. The susceptibility to HPV is disproportionate compared with other immunodeficiency conditions, suggesting that the product of the affected gene may be important in the natural control of this infection. We describe here the localization of the gene associated with WHIM syndrome to a region of roughly 12 cM on chromosome 2q21 and the identification of truncating mutations in the cytoplasmic tail domain of the gene encoding chemokine receptor 4 (CXCR4). Haplotype and mutation analyses in a pedigree transmitting myelokathexis as an apparently autosomal recessive trait support genetic heterogeneity for this aspect of the WHIM syndrome phenotype. Lymphoblastoid cell lines carrying a 19-residue truncation mutation show significantly greater calcium flux relative to control cell lines in response to the CXCR4 ligand, SDF-1, consistent with dysregulated signaling by the mutant receptor. The identification of mutations in CXCR4 in individuals with WHIM syndrome represents the first example of aberrant chemokine receptor function causing human disease and suggests that the receptor may be important in cell-mediated immunity to HPV infection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wetzler, M. et al. A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia. Am. J. Med. 89, 663–672 (1990).
Zuelzer, W.W. “Myelokathexis”—a new form of chronic granulocytopenia. Report of a Case. N. Engl. J. Med. 270, 699–704 (1964).
Mentzer, W.C. Jr., Johnston, R.B. Jr., Baehner, R.L. & Nathan, D.G. An unusual form of chronic neutropenia in a father and daughter with hypogammaglobulinaemia. Br. J. Haematol. 36, 313–322 (1977).
O'Regan, S., Newman, A.J. & Graham, R.C. 'Myelokathexis'. Neutropenia with marrow hyperplasia. Am. J. Dis. Child. 131, 655–658 (1977).
Dong, F. et al. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc. Natl. Acad. Sci. USA 91, 4480–4484 (1994).
Horwitz, M., Benson, K.F., Person, R.E., Aprikyan, A.G. & Dale, D.C. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat. Genet. 23, 433–436 (1999).
Dale, D.C. et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96, 2317–2322 (2000).
Devriendt, K. et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat. Genet. 27, 313–317 (2001).
Aprikyan, A.A. et al. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood 95, 320–327 (2000).
Taniuchi, S. et al. Dizygotic twin sisters with myelokathexis: mechanism of its neutropenia. Am. J. Hematol. 62, 106–111 (1999).
Hord, J.D., Whitlock, J.A., Gay, J.C. & Lukens, J.N. Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature. J. Pediatr. Hematol. Oncol. 19, 443–448 (1997).
Feng, Y., Broder, C.C., Kennedy, P.E. & Berger, E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein–coupled receptor. Science 272, 872–877 (1996).
Nagasawa, T. et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635–638 (1996).
Ma, Q. et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95, 9448–9453 (1998).
Tachibana, K. et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591–594 (1998).
Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I. & Littman, D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595–599 (1998).
Burger, J.A. et al. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1. Blood 96, 2655–2663 (2000).
Bohinjec, J. Myelokathexis: chronic neutropenia with hyperplastic bone marrow and hypersegmented neutrophils in two siblings. Blut 42, 191–196 (1981).
Signoret, N. et al. Differential regulation of CXCR4 and CCR5 endocytosis. J. Cell. Sci. 111, 2819–2830 (1998).
Haribabu, B. et al. Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization. J. Biol. Chem. 272, 28726–28731 (1997).
Arai, H., Monteclaro, F.S., Tsou, C.L., Franci, C. & Charo, I.F. Dissociation of chemotaxis from agonist-induced receptor internalization in a lymphocyte cell line transfected with CCR2B. Evidence that directed migration does not require rapid modulation of signaling at the receptor level. J. Biol. Chem. 272, 25037–25042 (1997).
Kraft, K. et al. Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 which regulate signaling and receptor internalization. J. Biol. Chem. 11, 34408–34418 (2001).
Onai, N. et al. Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine. Blood 96, 2074–2080 (2000).
Gorlin, R.J. et al. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am. J. Med. Genet. 91, 368–376 (2000).
Deng, H. et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661–666 (1996).
Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001).
Lathrop, G.M., Lalouel, J.M., Julier, C. & Ott, J. Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am. J. Hum. Genet. 37, 482–498 (1985).
Diaz, G.A., Khan, K.T. & Gelb, B.D. The autosomal recessive Kenny–Caffey syndrome locus maps to chromosome 1q42–q43. Genomics 54, 13–18 (1998).
Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. & Lander, E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58, 1347–1363 (1996).
Francois, F. & Klotman, M.E. Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages. J. Virol. 77, 2539–2549 (2003).
Acknowledgements
The authors thank the WHIM syndrome kindreds for their participation in this study, A. Au and S. Zhang for technical assistance and B. Gelb for thoughtful discussions and critical reading of the manuscript. This study was supported in part by National Institutes of Health grants to the Mount Sinai Child Health Research Center, Mount Sinai General Clinical Research Center and the Mount Sinai Flow Cytometry Shared Research Facility.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hernandez, P., Gorlin, R., Lukens, J. et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet 34, 70–74 (2003). https://doi.org/10.1038/ng1149
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1149
This article is cited by
-
WHIM Syndrome-linked CXCR4 mutations drive osteoporosis
Nature Communications (2023)
-
Heterogeneous genetic landscape of congenital neutropenia in Korean patients revealed by whole exome sequencing: genetic, phenotypic and histologic correlations
Scientific Reports (2022)
-
CXCR4 and anti-BCMA CAR co-modified natural killer cells suppress multiple myeloma progression in a xenograft mouse model
Cancer Gene Therapy (2022)
-
Genotype–phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4WHIM variants
Genes & Immunity (2022)
-
Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome
Journal of Clinical Immunology (2022)